Structures predicted by homology modelling with Robetta or modelled de-novo with evolutionary constraints using GREMLIN and Rosetta.
Filter list by:
Model | Method | Target | Status | Annotation | Organism | Community |
---|---|---|---|---|---|---|
IPD_14028 | comparative modelling | MygeA.17230.a | target approved | Pyruvate dehydrogenase E1 component subunit beta (MG_273) | Mycoplasma genitalium | internal |
IPD_14029 | comparative modelling | MygeA.17992.a | target approved | 30S ribosomal protein S7 (MG_088) | Mycoplasma genitalium | internal |
IPD_14030 | comparative modelling | MygeA.00008.a | target approved | Serine hydroxymethyltransferase (MG_394) | Mycoplasma genitalium | internal |
IPD_14031 | comparative modelling | MygeA.00058.a | target approved | Thioredoxin reductase (MG_102) | Mycoplasma genitalium | internal |
IPD_14032 | comparative modelling | MygeA.18852.a | target approved | 30S ribosomal protein S14 type Z (MG_164) | Mycoplasma genitalium | internal |
IPD_14033 | comparative modelling | MygeA.01129.a | target approved | ParA family protein MG470 (MG_470) | Mycoplasma genitalium | internal |
IPD_14034 | comparative modelling | MygeA.19062.a | target approved | tRNA pseudouridine synthase A (MG_182) | Mycoplasma genitalium | internal |
IPD_14035 | comparative modelling | MygeA.17369.a | target approved | ATP synthase subunit beta (MG_399) | Mycoplasma genitalium | internal |
IPD_14036 | comparative modelling | MygeA.00429.a | target approved | Probable ATP-dependent 6-phosphofructokinase (MG_215) | Mycoplasma genitalium | internal |
IPD_14037 | comparative modelling | MygeA.19936.b | target approved | Elongation factor 4 (MG_138) | Mycoplasma genitalium | internal |
IPD_14038 | comparative modelling | MygeA.19942.a | target approved | DegV domain-containing protein MG326 (MG_326) | Mycoplasma genitalium | internal |
IPD_14039 | comparative modelling | MygeA.19941.a | target approved | Uncharacterized protein MG414 (MG_414) | Mycoplasma genitalium | internal |
IPD_14040 | comparative modelling | MygeA.00557.a | target approved | Ribose-phosphate pyrophosphokinase (MG_058) | Mycoplasma genitalium | internal |
IPD_14041 | comparative modelling | MygeA.19116.a | target approved | Uncharacterized tRNA/rRNA methyltransferase MG252 (MG_252) | Mycoplasma genitalium | internal |
IPD_14042 | comparative modelling | MygeA.00057.b | target approved | Energy-coupling factor transporter ATP-binding protein EcfA1 (MG_179) | Mycoplasma genitalium | internal |
IPD_14043 | comparative modelling | MygeA.19094.a | target approved | Putative phosphatase/phosphodiesterase MG246 (MG_246) | Mycoplasma genitalium | internal |
IPD_14044 | comparative modelling | MygeA.19932.a | target approved | Putative ABC transporter ATP-binding protein MG014 (MG_014) | Mycoplasma genitalium | internal |
IPD_14045 | comparative modelling | MygeA.20192.a | target approved | Uncharacterized protein MG459 (MG_459) | Mycoplasma genitalium | internal |
IPD_14046 | comparative modelling | MygeA.18481.a | target approved | ATP synthase subunit b (MG_403) | Mycoplasma genitalium | internal |
IPD_14975 | comparative modelling | BrabA.17285.c | diffraction | Solute-binding protein/glutamate receptor:Ionotropic glutamate receptor:Bacterial extracellular solute-binding protein, family 3 | Brucella melitensis | internal |
IPD_15652 | comparative modelling | BewuA.18655.a | in PDB | Spike glycoprotein (S) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15657 | comparative modelling | BewuA.20418.a | selected | ORF7a | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15661 | comparative modelling | BewuA.18928.a | selected | orf1ab polyprotein nsp1 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15666 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp7 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15667 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp8 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |